EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Clinical approach for managing patients with unexpected CDH1 mutations: A case report

Yago Garitaonaindia, Miriam Méndez, Fátima Valentín, Lourdes Gutiérrez, Alberto Herreros de Tejada, Antonio Sánchez Ruiz, Mariano Provencio, Atocha Romero iD

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.2496 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Yago Garitaonaindia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Puerta de Hierro University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Stomach Neoplasms, Antigens, CD, Cadherins, Ovarian Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: SERMAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hereditary diffuse gastric cancer (HDGC) (OMIM# 137215) is an autosomal dominant cancer syndrome associated with CDH1 (OMIM# 192090) mutations. Prophylactic total gastrectomy (PTG) is the most recommended preventive treatment when a pathogenic mutation is found. However, the increasing use of genetic testing has led to the identification of incidental CDH1 mutations in individuals without a family history of gastric cancer. It remains unclear whether these patients should undergo prophylactic total gastrectomy.

Methods

Germline DNA, obtained from peripheral blood, was analysed by NGS.

Results

A 47‐year‐old woman was diagnosed with high‐grade serous ovarian carcinoma, FIGO stage IIIC, with a Homologous Recombination Deficiency (HRD) GIS status of 78 (positive, cut‐off: 43). She received chemotherapy and niraparib treatment. A multigene panel test revealed no pathogenic mutations in BRCA1 (OMIM# 113705) /BRCA2 (OMIM# 600185) genes, but a de novo deletion of exon 16 in CDH1 was found incidentally. She had no previous family history of gastric or breast cancer. The patient was enrolled in a surveillance program involving periodic endoscopy and was diagnosed with diffuse gastric cancer through biopsies of a pale area in the antrum after 1 year of close endoscopic follow‐up.

Conclusion

This case presents supportive evidence for the pathogenic classification of the loss of the last exon of CDH1 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAntigens, CDCadherinsOvarian NeoplasmsHumansFemaleMiddle AgedGastrectomyGerm-Line Mutation

Stichwörter der Autor:innen

CDH1HDGC

Substanzen

Antigens, CDCadherinsCDH1 protein, human

Autor:innen und Institutionen

  • Medical Oncology Department, Puerta de Hierro University Hospital, Madrid, Spain.
  • Gastroenterology and Hepatology Department, Endoscopy Unit Puerta de Hierro University Hospital, Madrid, Spain.

ORCID-Profile: Atocha Romero

Förderung

  • SERMAS

Zitieren

APA

Garitaonaindia, Y., Méndez, M., Valentín, F., Gutiérrez, L., de Tejada, A. H., Sánchez Ruiz, A., Provencio, M., & Romero, A. (2024). Clinical approach for managing patients with unexpected CDH1 mutations: A case report. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2496

Vancouver

Garitaonaindia Y, Méndez M, Valentín F, Gutiérrez L, de Tejada AH, Sánchez Ruiz A, et al. Clinical approach for managing patients with unexpected CDH1 mutations: A case report. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2496

BibTeX
@article{Garitaonaindia2024,
  author = {Garitaonaindia, Yago and Méndez, Miriam and Valentín, Fátima and Gutiérrez, Lourdes and de Tejada, Alberto Herreros and Sánchez Ruiz, Antonio and Provencio, Mariano and Romero, Atocha},
  title = {Clinical approach for managing patients with unexpected CDH1 mutations: A case report},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.2496}
}
Kostenlos starten →